A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA.Weight loss injections have become incredibly popular in the ...

Many stars have weighed in on injectables like Ozempic, Mounjaro and Wegovy. And with the stigma shifting, Rosie O'Donnell, Meghan Trainor, Scott Disick and others are proclaiming their benefits.

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...